RecruitingNCT07391410
Registry for Bone Metastases
The International Bone Metastasis Registry
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
500 participants
Start Date
Jan 13, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.
Eligibility
Min Age: 22 Years
Inclusion Criteria4
- Age ≥22 years
- Biopsy-proven or clinically obvious metastatic bone disease
- Symptomatic bone lesion requiring intervention
- This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above
Exclusion Criteria1
- Age <22 years
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07391410
Related Trials
Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort
NCT023564971 location
SBRT Technique Implementation for Spinal Metastases Irradiation
NCT074294222 locations
Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
NCT071460748 locations
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
NCT060654491 location
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
NCT064809555 locations